Annekathrin R.
- Country
- Germany
- Department
- Neurology
Research Overview
- A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Usnoflast in Adults with Amyotrophic Lateral Sclerosis
- Efficacy and Safety of Pridopidine in Participants with Amyotrophic Lateral Sclerosis: A Phase 3, Randomized, Double-blind, Placebo-controlled Study
- Evaluation of the Safety and Efficacy of AMX0035 (Phenylbutyrate, Ursodoxicoltaurine) in Adult Patients with Amyotrophic Lateral Sclerosis
Data & Insights
Has run more than one trial at 40 of 73 partner sites.
Specializations
Neurodegenerative Disorders
This investigator specializes in clinical research focused on Amyotrophic Lateral Sclerosis (ALS), conducting innovative therapeutic investigations for this progressive neurological condition.
- Disease Progression Assessment
- Motor Function Evaluation
- Neurological Disease Management
Their research encompasses evaluating novel therapeutic approaches for managing ALS symptoms and potentially slowing disease progression.
Therapeutic Development
The investigator's work centers on evaluating emerging therapeutic compounds for ALS treatment, including novel drug candidates and their potential neuroprotective properties.
- Drug Efficacy Assessment
- Safety Profile Evaluation
- Treatment Response Monitoring
Their research aims to expand treatment options for patients with ALS through systematic evaluation of innovative therapeutic agents.
Clinical Assessment
Expertise in conducting comprehensive clinical evaluations of ALS patients, focusing on disease progression patterns and therapeutic responses.
- Patient Safety Monitoring
- Treatment Tolerability Assessment
- Clinical Outcomes Measurement
The investigator employs systematic approaches to evaluate treatment effects and patient responses in ALS clinical research.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.